Pharmaceutical Impurity Synthesis and Isolation Services Report: Capitalize on a $2.1 Billion Market by 2030 as Tariffs and 8.9% Isolation Growth Reshape Competition Across Eurofins, WuXi AppTec, Cambrex and Charles River

The global pharmaceutical impurity synthesis and isolation services market is projected to grow from $1.3 billion in 2024 to $2.1 billion by 2030 at a 7.7% CAGR. Growth is driven by stricter regulatory requirements, increasing drug complexity, biologics expansion, and rising pharmaceutical outsourcing. Isolation services are expected to grow fastest at 8.9% CAGR, while analytical services will advance at 5.7% CAGR.